InvestorsHub Logo
Followers 6
Posts 186
Boards Moderated 0
Alias Born 02/25/2011

Re: daydreaming2 post# 87775

Monday, 01/19/2015 9:13:13 AM

Monday, January 19, 2015 9:13:13 AM

Post# of 403212
Well put. I suspect we've suffered a combination of:

• too-high expectations (that have not YET been met)
• impatience (day traders)
• panic (those investing late in the bull run)
• lack of new long investors (likely due to lack of public knowledge of CTIX)
• shorting (throwing gas on a fire).

I see it as a matter of endurance and patience. Things continue to progress. When Management stated that Brilacidin has so many potential uses that they have not yet calculated it's true value...I see that as a positive, not a negative. When they said they are frustrated that DF won't let them disclose more about Kevetrin...well, again a positive--it is illogical that they'd be in a rush to disclose anything other than good news.

I'm still buying.


Good morning all!

I am seeing it different. Seems like there are a lot of new faces that have found interest and are very inquisitive to what is going on. Some of them seem to be old faces with new names.... Some are old faces that we haven't seen in awhile and this is the time they stop and cause doubt and disruption.

Then there are the long term investors that have been here for awhile... there sediment seems to be that the science is there we are still up significantly for the 52 week pricing. The confidence is very high with all the recent information that has been released. Several are curious as to what caused this run down but none have been wavered, from what they say. I am not a BH, BK, Karin or TOB (several others also) but I do hold a relatively large position ( some I even picked up in the mid $4 range) I am not concerned. I have done my own DD, not just what is easily available here on the board. I haven't even pushed my travel plans out for the big BK island party!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News